Have You Met Turbo & Scott? FTC May Want to Meet this eBook for...
I just found this tweet from @Novartis:
"US only: Have you met Turbo & Scott? Visit http://t.co/yJDtSvhQ to read the TSC eBook or download Barks and Crafts"
At first, I thought this would...
Is 38 Hours Quick Enough to Respond to a Potentially Serious AE Tweet?
Subtitle: JNJ Responds to Adverse Event Reported Directly to @JNJComm via Twitter
There are probably more than 100 pharmaceutical company Twitter accounts such as @JNJComm, which posts news and information from Johnson...
Obama’s Executive Order Spurs Drug Industry to Cooperate with FDA to Ease Drug Shortages
This week marks the six-month anniversary of President Obama signing an Executive Order to help FDA in its efforts to prevent and resolve prescription drug shortages. Following the Executive Order, FDA...
Pharma Support of CME Infographic
Pharma support of CME continues to decline, but at a slower rate.
"Other" Sources of Revenue (eg, registration fees, grants from gov't or independent foundations) have taken up the slack and then...
Pfizer’s Lipitor Co-pay Card/PBM Discount Plan Fails
Yesterday, an attendee at the Marcus Evans PharmaMarketing Summit here in Chicago asked if Pfizer's innovative plan to extend the life of its Lipitor franchise after patent expiration was a public...
Type 2 Diabetes in Obese Children Proves Difficult to Treat with Drugs Alone
Metformin, "the only pill approved in the U.S. for treatment of children with type 2 diabetes is proving surprisingly ineffective, according to a new study, heightening worries about the fast-growing and...
Resurgence of Pharma Lobbying Spending
According to Open Secrets, which tracks industry lobbying, "the pharmaceutical industry as a whole spent $69.6 million on lobbying in the first three months" of 2012 (see "Pharma, Utilities and Big...
Novo Nordisk is Back on Pinterest with Patient Stories
Novo Nordisk is back on Pinterest! Recall that Novo "de-pinned" all its images a few days after I first discovered them on Pinterest (see "Pharma Pinterest Update: Bayer US Pins, Novo...
Device Makers, e.g. Johnson & Johnson, May Benefit Most from FDA User Fee Bill
"Put simply," says AdvaMed, the trade association of the medical device industry, "the is good for FDA; it is good for industry; and most of all, it is good for...
As Pharma Spends More on Digital, External Digital Agencies Receive Poor Ratings from Marketing...
Pharmaceutical brand teams are generally dissatisfied with their outsourced digital marketing, according to a study by Cutting Edge Information (see press release).
In surveys and interviews, executives acknowledged the challenges that their...
